Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mesenchymal Stem Cell Secretome in Rheumatoid Arthritis
NCT05925647Phase 2Completed
- Sponsor
- Universitas Sebelas Maret
- Start
- Aug 2022
- Primary completion
- Feb 2023
- Modality
- Lipid-based Nanoparticles, Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of mesenchymal stem cell secretome in rheumatoid arthritis (RA), sponsored by Universitas Sebelas Maret. Started Aug 2022; status: completed.
02
Drugs
mesenchymal stem cell secretome
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT05925647.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05925647.